-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Upgrades Ardelyx to Overweight, Raises Price Target to $16

Benzinga·01/09/2026 13:18:19
Listen to the news
Piper Sandler analyst Christopher Raymond upgrades Ardelyx (NASDAQ:ARDX) from Neutral to Overweight and raises the price target from $10 to $16.